Phase Ⅱ, Randomized, Double-Blind,Double-Dummy Study Evaluating Safety,Tolerability,Efficacy of Meropenem-FL058 in Adult Patients With Complicated Urinary Tract Infections, Including Acute Pyelonephritis
Latest Information Update: 08 Sep 2023
At a glance
- Drugs FL 058 (Primary) ; Meropenem (Primary) ; Piperacillin/tazobactam
- Indications Pyelonephritis; Urinary tract infections
- Focus Therapeutic Use
- Sponsors Qilu Pharmaceutical
- 05 Oct 2021 New trial record